Targeting BTLA with the peptide inhibitor HVEM(14-39) – A new way to restore the activity of T cells in melanoma
Article in Biomedicine & Pharmacotherapy (May 2024)
The most recent citing publications are shown below. View all 24 publications that cite this research output on Dimensions.
Article in Biomedicine & Pharmacotherapy (May 2024)
Article in Endocrine Metabolic & Immune Disorders - Drug Targets (January 2024)
Article in European Journal of Pharmaceutical Sciences (December 2023)